TCMBANKIN012501 |
Suaveolic acid |
(1R,4aS,7S)-8-hydroxy-1,4a-dimethyl-7-propan-2-yl-2,3,4,5,6,7,8,9,10,10a-decahydrophenanthrene-1-carboxylic acid; suaveolic acid; suaveolicacid; AC1NT0M7 |
C20H32O3 |
320.47 |
CC(C)C1CCC2=C(C1O)CCC3C2(CCCC3(C)C(=O)O)C |
TCMBANKIN061576 |
subaphylline |
Subaphylline; (2E)-N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid; AX8235677; N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enimidic acid; TC-158316; SFUVCMKSYKHYLD-FNORWQNLSA-N; KB-258187; 2-Propenamide, N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)- (9CI); AK104138; 501-13-3; MFCD01736565; NSC602818; 4-Oxy-3-methoxycinnamylputrescine; AKOS016006183; 2-Propenamide, N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)-; AC1NQZ3Q; (E)-N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamide; CHEBI:9299; LS-53858; (2E)-N-(4-AMINOBUTYL)-3-(4-HYDROXY-3-METHOXYPHENYL)PROP-2-ENAMIDE; N-Feruloylputrescine; (E)-N-(4-aminobutyl)-3-(4-hydroxy-3-methoxy-phenyl)prop-2-enamide; (E)-N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide; Subaphyllin; N-(4-Aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)acrylamide; Feruloylputrescine; ZINC1531868; MolPort-044-723-792; trans-N-Feruloylputrescine; 6850AB; C10497; 91000-11-2; AK677578; CINNAMAMIDE, N-(4-AMINOBUTYL)-4-HYDROXY-3-METHOXY-; AJ-26737; NSC-602818; (2E)-N-(4-Aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)-2-propenamide #; N-(E)-Feruloylputrescine; MolPort-023-333-229; N-(4-Aminobutyl)-4-hydroxy-3-methoxycinnamamide; subaphyllin |
C14H20N2O3 |
264.32 g/mol |
COC1=C(C=CC(=C1)C=CC(=O)NCCCCN)O |